SUSCEPTIBILITY TEST FOR FUNGI: CLINICAL AND LABORATORIAL CORRELATIONS IN MEDICAL MYCOLOGY

Use of the VITEK 2 system to identify and test the antifungal susceptibility of clinically relevant yeast species

(2014) MSC Melhem et al.   BRAZILIAN JOURNAL OF MICROBIOLOGY

Current status of antifungal resistance and its impact on clinical practice

(2014) Laura Alcazar-Fuoli et al.   BRITISH JOURNAL OF HAEMATOLOGY

Multicenter Evaluation of the New Vitek 2 Yeast Susceptibility Test Using New CLSI Clinical Breakpoints for Fluconazole

(2014) M. A. Pfaller et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Comparative Evaluation of a New Commercial Colorimetric Microdilution Assay (SensiQuattro Candida EU) with MIC Test Strip and EUCAST Broth Microdilution Methods for Susceptibility Testing of Invasive Candida Isolates

(2014) Hedda Luise Koehling et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Comparison between the EUCAST Procedure and the Etest for Determination of the Susceptibility of Candida Species Isolates to Micafungin

(2013) Laura Judith Marcos-Zambrano et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Candida tropicalis Antifungal Cross-Resistance Is Related to Different Azole Target (Erg11p) Modifications

(2013) A. Forastiero et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Epidemiological changes with potential implication for antifungal prescription recommendations for fungaemia: data from a nationwide fungaemia surveillance programme

(2013) M.C. Arendrup et al.   CLINICAL MICROBIOLOGY AND INFECTION

Epidemiological Cutoff Values for Fluconazole, Itraconazole, Posaconazole, and Voriconazole for Six Candida Species as Determined by the Colorimetric Sensititre YeastOne Method

(2013) E. Canton et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Caspofungin Etest Susceptibility Testing of Candida Species: Risk of Misclassification of Susceptible Isolates of C. glabrata and C. krusei when Adopting the Revised CLSI Caspofungin Breakpoints

(2012) Maiken Cavling Arendrup et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Comparison of the Sensititre YeastOne colorimetric antifungal panel with CLSI microdilution for antifungal susceptibility testing of the echinocandins against Candida spp., using new clinical breakpoints and epidemiological cutoff values

(2012) M.A. Pfaller et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Hidden Killers: Human Fungal Infections

(2012) G. D. Brown et al.   Science Translational Medicine

Antifungal Drug Resistance: Mechanisms, Epidemiology, and Consequences for Treatment

(2011) Michael A. Pfaller   AMERICAN JOURNAL OF MEDICINE

Evaluation of CLSI M44-A2 Disk Diffusion and Associated Breakpoint Testing of Caspofungin and Micafungin Using a Well-Characterized Panel of Wild-Type andfksHot Spot Mutant Candida Isolates

(2011) Maiken Cavling Arendrup et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Clinical breakpoints for the echinocandins and Candida revisited: Integration of molecular, clinical, and microbiological data to arrive at species-specific interpretive criteria

(2011) M.A. Pfaller et al.   DRUG RESISTANCE UPDATES

Multicenter Comparison of the Vitek 2 Antifungal Susceptibility Test with the CLSI Broth Microdilution Reference Method for Testing Caspofungin, Micafungin, and Posaconazole against Candida spp.

(2011) J. F. Peterson et al.   JOURNAL OF CLINICAL MICROBIOLOGY

The current role of the reference procedures by CLSI and EUCAST in the detection of resistance to antifungal agentsin vitro

(2010) Manuel Cuenca-Estrella et al.   Expert Review of Anti-Infective Therapy

Comparison of the Vitek 2 Antifungal Susceptibility System with the Clinical and Laboratory Standards Institute (CLSI) and European Committee on Antimicrobial Susceptibility Testing (EUCAST) Broth Microdilution Reference Methods and with the Sensititre YeastOne and Etest Techniques for In Vitro Detection of Antifungal Resistance in Yeast Isolates

(2010) M. Cuenca-Estrella et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS

(2009) Benjamin J Park et al.   AIDS

The Effect of Time to Antifungal Therapy on Mortality in Candidemia Associated Septic Shock

(2009) Gourang P Patel et al.   AMERICAN JOURNAL OF THERAPEUTICS

Activity of Posaconazole and Other Antifungal Agents against Mucorales Strains Identified by Sequencing of Internal Transcribed Spacers

(2009) A. Alastruey-Izquierdo et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Possible Environmental Origin of Resistance of Aspergillus fumigatus to Medical Triazoles

(2009) E. Snelders et al.   APPLIED AND ENVIRONMENTAL MICROBIOLOGY

The changing face of epidemiology of invasive fungal disease in Europe

(2009) Cornelia Lass-Flörl   MYCOSES

In Vitro Activities of 35 Double Combinations of Antifungal Agents against Scedosporium apiospermum and Scedosporium prolificans

(2008) M. Cuenca-Estrella et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

EUCAST Technical Note on the method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for conidia–forming moulds

(2008)   CLINICAL MICROBIOLOGY AND INFECTION

Antifungal susceptibility profile of clinical Fusarium spp. isolates identified by molecular methods

(2008) A. Alastruey-Izquierdo et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Correlation of MIC with Outcome for Candida Species Tested against Caspofungin, Anidulafungin, and Micafungin: Analysis and Proposal for Interpretive MIC Breakpoints

(2008) M. A. Pfaller et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Epidemiology and outcome ofScedosporium prolificansinfection, a review of 162 cases

(2008) Juan Luis Rodriguez-Tudela et al.   MEDICAL MYCOLOGY

Epidemiological trends in skin mycoses worldwide

(2008) Blanka Havlickova et al.   MYCOSES